The addition of pharmacological treatment to physiotherapy in pain reduction of TMD-myalgia patients
Background: Myalgia is the most common cause of Temporomandibular Disorders (TMDs) pain, which has a dull and mild character. In some patients with high somatization, it can present itself as severe pain, which can complicate the treatment. Additional pharmacological treatment may thus be needed. Ca...
Saved in:
Main Authors: | Carolina Marpaung (Author), Hasti Parvaneh (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polymorphisms in the HTR2A and HTR3A Genes Contribute to Pain in TMD Myalgia
by: Sofia Louca Jounger, et al.
Published: (2021) -
Local myalgia compared to myofascial pain with referral according to the DC/TMD: Axis I and II results
by: Orit Winocur-Arias, et al.
Published: (2022) -
The effectiveness of stabilization appliance therapy among patients with myalgia
by: Tomoyasu Noguchi, et al.
Published: (2020) -
RYR1 Mutations, Exertional Myalgia and Rhabdomyolysis
by: J Gordon Millichap
Published: (2013) -
TMD and chronic pain: A current view
by: Bruno D'Aurea Furquim, et al.
Published: (2015)